LIVN LivaNova PLC

  1. Stocks
  2. Healthcare
  3. NASDAQ: LIVN

Price (delayed)

$53.62

Market cap

$2.9B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.59

Enterprise value

$2.96B

LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through ...

Highlights
LivaNova's EPS has surged by 61% YoY
The net income has soared by 61% YoY
LIVN's debt is up by 17% year-on-year and by 6% since the previous quarter
The equity has declined by 4.4% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.livanova.com
Peers: OFIX NVRO

Key stats

What are the main financial stats of LIVN
Market
Shares outstanding
54.15M
Market cap
$2.9B
Enterprise value
$2.96B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.37
Price to sales (P/S)
2.44
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.49
Earnings
Revenue
$1.19B
EBIT
-$63.99M
EBITDA
-$4.95M
Free cash flow
$30.44M
Per share
EPS
-$0.59
Free cash flow per share
$0.56
Book value per share
$22.64
Revenue per share
$21.94
TBVPS
$26.55
Balance sheet
Total assets
$2.46B
Total liabilities
$1.24B
Debt
$668.18M
Equity
$1.22B
Working capital
$712.25M
Liquidity
Debt to equity
0.55
Current ratio
3.17
Quick ratio
2.52
Net debt/EBITDA
-10.61
Margins
EBITDA margin
-0.4%
Gross margin
67.9%
Net margin
-2.7%
Operating margin
-4.2%
Efficiency
Return on assets
-1.3%
Return on equity
-2.6%
Return on invested capital
-6%
Return on capital employed
-3%
Return on sales
-5.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

LIVN stock price

How has the LivaNova stock price performed over time
Intraday
0.32%
1 week
1.34%
1 month
-1.56%
1 year
-8.92%
YTD
3.63%
QTD
-2.19%

Financial performance

How have LivaNova's revenue and profit performed over time
Revenue
$1.19B
Gross profit
$804.56M
Operating income
-$49.91M
Net income
-$31.77M
Gross margin
67.9%
Net margin
-2.7%
LIVN's net margin has soared by 65% year-on-year
The net income has soared by 61% YoY
LivaNova's operating margin has surged by 51% YoY and by 29% QoQ
The company's operating income rose by 44% YoY and by 27% QoQ

Growth

What is LivaNova's growth rate over time

Valuation

What is LivaNova stock price valuation
LIVN P/E details
P/E
N/A
P/B
2.37
P/S
2.44
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.49
LivaNova's EPS has surged by 61% YoY
The price to book (P/B) is 9% lower than the 5-year quarterly average of 2.6 but 2.6% higher than the last 4 quarters average of 2.3
The equity has declined by 4.4% since the previous quarter
The price to sales (P/S) is 21% lower than the 5-year quarterly average of 3.1 and 2.4% lower than the last 4 quarters average of 2.5
LivaNova's revenue has increased by 13% YoY and by 2.7% from the previous quarter

Efficiency

How efficient is LivaNova business performance
LivaNova's return on sales has shrunk by 184% QoQ
The ROIC has plunged by 161% from the previous quarter
The company's return on assets has surged by 64% YoY
The return on equity has surged by 61% year-on-year

Dividends

What is LIVN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LIVN.

Financial health

How did LivaNova financials performed over time
The company's total assets is 99% higher than its total liabilities
LivaNova's total liabilities has increased by 16% YoY and by 7% QoQ
LivaNova's quick ratio has increased by 14% YoY and by 6% QoQ
LIVN's debt is 45% smaller than its equity
LIVN's debt is up by 17% year-on-year and by 6% since the previous quarter
LIVN's debt to equity is up by 17% year-on-year and by 12% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.